Thyrocare Technologies jumps on completing acquisition of 100% stake in Think Health
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Thyrocare Technologies is currently trading at Rs. 717.15, up by 75.35 points or 11.74% from its previous closing of Rs. 641.80 on the BSE.
The scrip opened at Rs. 646.00 and has touched a high and low of Rs. 722.00 and Rs. 643.00 respectively. So far 25223 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 722.00 on 28-Jan-2024 and a 52 week low of Rs. 416.00 on 29-Mar-2023.
Last one week high and low of the scrip stood at Rs. 722.00 and Rs. 601.10 respectively. The current market cap of the company is Rs. 3447.22 crore.
The promoters holding in the company stood at 71.11%, while Institutions and Non-Institutions held 17.24% and 11.65% respectively.
Thyrocare Technologies has completed the acquisition by way purchase of 100% equity shares in Think Health Diagnostic (Think Health) from all the existing shareholders of Think Health on February 27, 2024 and consequently Think Health has become wholly-owned subsidiary company of Thyrocare with effective from February 27, 2024.
Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in several cities / towns in India and internationally. Thyrocare is India's first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.
.jpg)
